Rankings
▼
Calendar
AMRN Q3 2024 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$42M
-36.0% YoY
Gross Profit
$16M
38.5% margin
Operating Income
-$25M
-59.5% margin
Net Income
-$25M
-59.4% margin
EPS (Diluted)
$-1.22
QoQ Revenue Growth
-37.4%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$751M
Total Liabilities
$219M
Stockholders' Equity
$531M
Cash & Equivalents
$157M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$42M
$66M
-36.0%
Gross Profit
$16M
$30M
-45.4%
Operating Income
-$25M
-$21M
-17.3%
Net Income
-$25M
-$19M
-30.2%
Revenue Segments
Product
$42M
99%
Licensing And Royalty
$446,000
1%
← FY 2024
All Quarters
Q4 2024 →